Mandate

VINGE ADVISES GRÄNGES IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

October 10, 2014

Vinge advises Gränges AB (publ) in connection with the company’s listing on Nasdaq Stockholm.

Gränges is a leading global supplier of rolled products for the brazed aluminum heat exchanger industry. The Company develops, produces and markets advanced materials that enhance both production economy during the customer manufacturing process, as well as the performance of the final products, the brazed heat exchangers. Gränges’ vision is to help create smaller, lighter and more designable heat exchangers, to increase economic efficiency and reduce environmental impact. The Swedish language prospectus was published on 29 September 2014 and the first day of trading was 10 October 2014. The offering price has been set at SEK 42.50 per share, corresponding to a market value of Gränges of approximately SEK 3,200 million.

Vinge’s team primarily consisted of Carl Gustaf de Geer, Jesper Schönbeck, Charlotte Levin, Katarina Nilsson, Kristian Ford, Rikard Lindahl, Filip Brosset and Henrik Jonsson.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026